Signal Explorer
10-K · 10-Q · 8-K · last 6 months · ← back to feed
Curanex Pharmaceuticals Inc
CURX
Other
Form S3 Shelf Registration Disclosure
Litigation Defense Assertion
Other
Reverse Stock Split Effected
Nasdaq Minimum Bid Price Delisting Notice
Other
Reverse Stock Split Effected
Nyse Listing Disclosure
Nasdaq Minimum Bid Price Delisting Notice
Fractional Share Cash Payment
Equity Plan Board Approval Conditional On Shareholder Vote
Other
Warrant Valued Black Scholes
Net Loss Reported
Capital Raising Uncertainty Disclosed
Restrictive Debt Covenants Disclosure
Reverse Stock Split Effected
Other Income Expense Disclosure
Nasdaq Minimum Bid Price Delisting Notice
Nyse Listing Disclosure
Form S3 Shelf Registration Disclosure
Equity Compensation Accounting Policy
Ipo Or Capital Raising Completion
Equity Award Plan Types Enumerated
Shares Outstanding Disclosure
Incorporation Or Reincorporation Disclosure
Core
Indication Expansion
Other
Net Loss Reported
Ipo Net Proceeds Disclosure
Ipo Or Capital Raising Completion
Other Income Expense Disclosure
Nyse Listing Disclosure
Incorporation Or Reincorporation Disclosure
Shares Outstanding Disclosure
Institutional Investment
Operating Lease Rent Expense Disclosed
Nasdaq Minimum Bid Price Delisting Notice
Core
Indication Expansion
Lead Asset Progress
Biotech v3
Ai Drug Discovery Investment
Core
Clinical Trial Result
Indication Expansion
Lead Asset Progress
Clinical Hold
Secondary Endpoint Mentioned
Combination Therapy Mentioned
Other
Interim Data Positive
Patient Retention High
Fda Aligned
Biotech v3
Ind Submission Planned
Other
Nasdaq Minimum Bid Price Delisting Notice